Hematologic Malignancy Center
The Hematologic
Malignancy Center offers specialized programs for the treatment of leukemia, lymphoma, histiocytosis, and lymphadenopathy through Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children's Hospital. Our center played a key role in refining treatment for childhood leukemia, resulting in today's cure rates of more than 90 percent
for pediatric acute lymphoblastic leukemia, and we continue to lead
high-impact clinical trials designed to increase cure rates and decrease
treatment-related toxicities for long-term survivors.
Conditions We Treat
Leukemia
Lymphoma
Histiocytosis
Specialized
Treatment Programs for Hematologic Malignancies
Please visit the Dana-Farber
Cancer Institute website to learn more about our Hematologic
Malignancy Center, including information about: